The CTIC chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CTIC chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CTIC stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CTIC Detailed Price Forecast - CNN Money||View CTIC Detailed Summary - Google Finance|
|View CTIC Detailed Summary - Yahoo! Finance||View CTIC Stock Research & Analysis - Zacks.com|
|View CTIC Trends & Analysis - Trade-Ideas||View CTIC Major Holders - Barrons|
|View CTIC Call Transcripts - NASDAQ||View CTIC Breaking News & Analysis - Seeking Alpha|
|View CTIC Annual Report - CompanySpotlight.com||View CTIC OTC Short Report - OTCShortReport.com|
|View CTIC Fundamentals - TradeKing||View CTIC SEC Filings - Bar Chart|
|View Historical Prices for CTIC - The WSJ||View Performance/Total Return for CTIC - Morningstar|
|View the Analyst Estimates for CTIC - MarketWatch||View the Earnings History for CTIC - CNBC|
|View the CTIC Earnings - StockMarketWatch||View CTIC Buy or Sell Recommendations - MacroAxis|
|View the CTIC Bullish Patterns - American Bulls||View CTIC Short Pain Metrics - ShortPainBot.com|
|View CTIC Stock Mentions - StockTwits||View CTIC Stock Mentions - PennyStockTweets|
|View CTIC Stock Mentions - Twitter||View CTIC Investment Forum News - Investor Hub|
|View CTIC Stock Mentions - Yahoo! Message Board||View CTIC Stock Mentions - Seeking Alpha|
|View Insider Transactions for CTIC - SECform4.com||View Insider Transactions for CTIC - Insider Cow|
|View CTIC Major Holdings Summary - CNBC||View Insider Disclosure for CTIC - OTC Markets|
|View Insider Transactions for CTIC - Yahoo! Finance||View Institutional Holdings for CTIC - NASDAQ|
|View CTIC Stock Insight & Charts - FinViz.com||View CTIC Investment Charts - StockCharts.com|
|View CTIC Stock Overview & Charts - BarChart||View CTIC User Generated Charts - Trading View|
CTI BioPharma Announces Restructuring Plan
Posted on Thursday December 13, 2018
SEATTLE, Dec. 13, 2018 /PRNewswire/ -- CTI BioPharma Corp. (CTIC) announced today a restructuring plan to improve efficiencies and reduce costs within the organization. As part of this plan, workforce reductions have been implemented that impact approximately 50 percent of the total number of the Company's employees. Cost savings of approximately $20 million primarily associated with reduced employee costs are expected over three years.
CTI BioPharma Provides Program Update Following Regulatory Feedback on Pacritinib Development from the European Medicines Agency
Posted on Monday November 26, 2018
SEATTLE, Nov. 26, 2018 /PRNewswire/ -- CTI BioPharma Corp. (CTIC) today announced that the Company has received a second round of questions related to the Day 180 List of Outstanding Issues, for the marketing authorization application (MAA) for pacritinib, from the European Medicines Agency (EMA). The Company plans to submit responses to the EMA, which will include data from the ongoing open label PAC203 trial, by the end of the year.
Detailed Research: Economic Perspectives on Jason Industries, XBiotech, Dynatronics, Evolving, CTI BioPharma, and Charles & Colvard — What Drives Growth in Today's Competitive Landscape
Posted on Friday November 23, 2018
NEW YORK, Nov. 23, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
CTI BioPharma (CTIC) Reports Q3 Loss, Tops Revenue Estimates
Posted on Thursday November 01, 2018
CTI BioPharma (CTIC) delivered earnings and revenue surprises of -30.00% and 20.50%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?